- Pfizer: Expects to be No.1 in Japan Generic Drugs (Reuters)
- Drug giants seek help to cut costs (PharmacyEurope)
- AstraZeneca to Cut 8000 Pharmaceutical Jobs (Pharmaceutical Jobs)
- GSK Silent on Job Cut Rumors, New Tykerb OK (PharmaTimes)
- Scientists Say Crack HIV/AIDS Puzzle for Drugs (Reuters)
- Boston Scientific to Pay J&J $1.73 Bln to Resolve Patent Dispute (Bloomberg)
- Gates: $10 Billion More for Vaccines Over 10 Years (PharmaTimes)
- F.D.A. Aims at Doctors’ Drug Pitches (The New York Times)
- Ipsen Sales Rise as Wrinkles Therapy Revenues Grow (PharmaTimes)
- Lilly Reports Fourth-Quarter and Full-Year 2009 Results (World Pharma News)
- Zyprexa (olanzapine): Use in Adolescents – Clinicians should consider potential long-term risks when prescribing to adolescents (PharmaLive)
SUBSCRIBE